West Pharmaceutical Services (WST) Treasury Shares (2009 - 2026)

West Pharmaceutical Services has disclosed Treasury Shares across 18 years of filings, most recently posting $1.4 billion for Q1 2026.

• Treasury Shares for Q1 2026 came in at $1.4 billion, up 18.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 18.56% YoY), and the FY2025 annual result was $1.1 billion, up 5.21% from the prior year.
• Treasury Shares came in at $1.4 billion for Q1 2026 at West Pharmaceutical Services, up from $1.1 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.5 million in Q1 2025 to a low of $77329.0 in Q3 2023.
• The 5-year median for Treasury Shares is $1.3 million (2022), against an average of $1.9 million.
• Across the five-year window, Treasury Shares soared 123.51% in 2024 and grew 5.21% in 2025, its largest moves.
• West Pharmaceutical Services' Treasury Shares stood at $370.9 million in 2022, then soared by 71.91% to $637.6 million in 2023, then surged by 65.79% to $1.1 billion in 2024, then advanced by 5.21% to $1.1 billion in 2025, then rose by 24.0% to $1.4 billion in 2026.
• The last three Treasury Shares figures came in at $1.4 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.